Potassium-sparing diuretics: spironolactone v. triamterene and amiloride
Author information unavailable
Abstract
Author information unavailable
Abstract
Spironolactone (Aldactone-A),1 triamterene (Dytac)2 3 and amiloride (Midamor)2 are all potassium-sparing diuretics which we have reviewed separately. Spironolactone is a steroid which competitively antagonises aldosterone in the distal renal tubule; triamterene and amiloride directly affect electrolyte transport in the distal tubule without antagonising aldo-sterone. However, the ultimate effects of these drugs are quite similar, and it is not clear whether they should be regarded as interchangeable or whether their uses should differ.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Spironolactone (Aldactone-A),1 triamterene (Dytac)2 3 and amiloride (Midamor)2 are all potassium-sparing diuretics which we have reviewed separately. Spironolactone is a steroid which competitively antagonises aldosterone in the distal renal tubule; triamterene and amiloride directly affect electrolyte transport in the distal tubule without antagonising aldo-sterone. However, the ultimate effects of these drugs are quite similar, and it is not clear whether they should be regarded as interchangeable or whether their uses should differ.
Key concepts: Triamterene, Amiloride, Spironolactone, Aldosterone, Potassium, Chemistry, Pharmacology, Endocrinology